The stock is down 17.3% since reporting ... Is now the time to buy ANI Pharmaceuticals? Access our full analysis of the earnings results here, it’s free. Formed in 2020 through the merger of Mylan and ...

Detailed price information for Elanco Animal Health Inc (ELAN-N) from The Globe and Mail including charting and trades.

Viatris Inc., formed in 2020 through the merger of Mylan and Upjohn (a former ... as a significant player in the pharmaceutical industry. The company’s stock has shown mixed performance, with ...

Investors in Pieris Pharmaceuticals ... Investors in Mylan N.V. (NASDAQ:MYL) need to pay close attention to the stock based on moves in the options market lately. That ...

Keeping that in mind, here is one healthcare stock poised to generate sustainable market-beating returns and two we’re swiping left on. Formed in 2020 through the merger of Mylan and Upjohn ...

The stock is down ... now the time to buy ANI Pharmaceuticals? Access our full analysis of the earnings results here, it’s ...

“The supplier of Estradiol TDP Mylan has assured Pharmac that it can produce enough patches to meet the demand in New Zealand. This is why our proposal is to have two brands funded. Pharmac also funds ...

Shares in Adamis Pharmaceuticals have been poleaxed by ... because of manufacturing issues. Adamis’ stock fell more than 50% into penny share territory after it received the complete response ...

The stock is priced at a 38% discount to our ... Pfizer’s size establishes one of the largest economies of scale in the pharmaceutical industry. In a business where drug development needs ...

Rural Women New Zealand (RWNZ) says it welcomes recently announced consultation on Pharmac’s funding of ostradiol patches ...